HEPA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Hepion Pharmaceuticals Inc (HEPA).


$14.05M Market Cap.

As of 04/16/2024 5:00 PM ET (MRY) • Disclaimer

HEPA Market Cap. (MRY)


HEPA Shares Outstanding (MRY)


HEPA Assets (MRY)


Total Assets

$18.09M

Total Liabilities

$10.81M

Total Investments

$0

HEPA Income (MRY)


Revenue

$0

Net Income

-$48.93M

Operating Expense

$48.45M

HEPA Cash Flow (MRY)


CF Operations

-$40.89M

CF Investing

-$14.30K

CF Financing

$4.49M

HEPA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

0%

0%

-

2019

$0

0%

-

0%

-

HEPA Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

$18,094,397 (-69.97%)

$60,244,452 (-41.82%)

$103,552,479 (112.87%)

$48,645,253 (136.01%)

Assets Current

$17,487,840 (-69.05%)

$56,496,073 (-42.03%)

$97,451,768 (128.58%)

$42,634,299 (196.30%)

Assets Non-Current

$606,557 (-83.82%)

$3,748,379 (-38.56%)

$6,100,711 (1.49%)

$6,010,954 (-3.41%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$1,870,924 (0.00%)

$1,870,924 (0.00%)

Shareholders Equity

$7,280,807 (-85.40%)

$49,855,937 (-46.39%)

$92,995,003 (129.50%)

$40,520,391 (159.47%)

Property Plant & Equipment Net

$242,365 (83.33%)

$132,205 (-71.04%)

$456,461 (-31.35%)

$664,932 (-22.24%)

Cash & Equivalents

$14,785,880 (-71.12%)

$51,189,088 (-43.96%)

$91,348,967 (124.30%)

$40,726,838 (192.52%)

Accumulated Other Comprehensive Income

-$78,779 (12.63%)

-$90,168 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$2,348,829 (-11.89%)

$2,665,896 (9.00%)

$2,445,837 (-34.29%)

$3,722,429 (657.27%)

Accumulated Retained Earnings (Deficit)

-$224,627,386 (-27.85%)

-$175,701,344 (-31.61%)

-$133,501,295 (-28.24%)

-$104,105,463 (-24.30%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$409,022 (0.00%)

$409,022 (0.00%)

$409,022 (0.00%)

Total Debt

$209,020 (289.86%)

$53,614 (-83.09%)

$316,992 (-57.86%)

$752,166 (-6.85%)

Debt Current

$115,916 (116.20%)

$53,614 (-79.89%)

$266,650 (-4.71%)

$279,826 (4.92%)

Debt Non-Current

$93,104 (0%)

$0 (0%)

$50,342 (-89.34%)

$472,340 (-12.65%)

Total Liabilities

$10,813,590 (4.09%)

$10,388,515 (-1.60%)

$10,557,476 (29.94%)

$8,124,862 (62.66%)

Liabilities Current

$5,290,096 (-32.92%)

$7,885,722 (-3.91%)

$8,206,396 (76.03%)

$4,661,827 (189.65%)

Liabilities Non-Current

$5,523,494 (120.69%)

$2,502,793 (6.45%)

$2,351,080 (-32.11%)

$3,463,035 (2.29%)

HEPA Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$9,618,298 (-7.06%)

$10,348,465 (3.40%)

$10,008,173 (22.82%)

$8,148,803 (77.69%)

Research & Development Expense

$35,639,656 (7.12%)

$33,269,337 (63.12%)

$20,395,136 (70.00%)

$11,997,272 (276.79%)

Operating Expenses

$48,447,954 (6.51%)

$45,488,726 (49.62%)

$30,403,309 (50.91%)

$20,146,075 (159.28%)

Interest Expense

$9,465 (-6.88%)

$10,164 (14.73%)

$8,859 (-71.63%)

$31,229 (-94.37%)

Income Tax Expense

-$409,022 (85.82%)

-$2,883,849 (0%)

$0 (0%)

$30,584 (103.37%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$48,926,042 (-15.94%)

-$42,200,049 (-28.96%)

-$32,722,168 (-60.77%)

-$20,353,938 (-189.23%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$48,926,042 (-15.94%)

-$42,200,049 (-28.96%)

-$32,722,168 (-60.77%)

-$20,353,938 (-189.23%)

Preferred Dividends Income Statement Impact

$0 (0%)

$3,137,500 (0%)

$0 (0%)

$5,287 (-99.90%)

Net Income Common Stock

-$48,926,042 (-7.92%)

-$45,337,549 (-38.55%)

-$32,722,168 (-60.72%)

-$20,359,225 (-63.13%)

Weighted Average Shares

$3,970,810 (4.18%)

$3,811,472 (8.45%)

$3,514,577 (626.31%)

$483,892 (373.65%)

Weighted Average Shares Diluted

$3,970,810 (4.18%)

$3,811,472 (8.45%)

$3,514,577 (626.31%)

$483,892 (373.65%)

Earning Before Interest & Taxes (EBIT)

-$49,325,599 (-9.43%)

-$45,073,734 (-37.78%)

-$32,713,309 (-61.21%)

-$20,292,125 (-174.55%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$48,447,954 (-6.51%)

-$45,488,726 (-49.62%)

-$30,403,309 (-50.91%)

-$20,146,075 (-159.28%)

HEPA Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

-$14,304 (-1.66%)

-$14,070 (89.21%)

-$130,405 (-52.01%)

-$85,789 (-66.68%)

Net Cash Flow from Financing

$4,494,950 (187.49%)

-$5,137,500 (-106.27%)

$81,977,015 (90.40%)

$43,054,857 (130.15%)

Net Cash Flow from Operations

-$40,888,878 (-16.96%)

-$34,961,171 (-11.97%)

-$31,224,481 (-93.16%)

-$16,165,202 (-113.68%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$36,403,208 (9.35%)

-$40,159,879 (-179.33%)

$50,622,129 (88.86%)

$26,803,866 (141.68%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$14,304 (-1.66%)

-$14,070 (89.21%)

-$130,405 (-52.01%)

-$85,789 (-66.68%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

-$176,585 (-200.00%)

$176,585 (115.77%)

Issuance (Purchase) of Equity Shares

$4,494,950 (0%)

$0 (0%)

$82,153,600 (91.60%)

$42,878,272 (338.69%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$5,024 (110.66%)

-$47,138 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,340,311 (-47.50%)

$2,552,736 (-45.32%)

$4,668,815 (96.22%)

$2,379,360 (3495.50%)

Depreciation Amortization & Accretion

$67,131 (-13.34%)

$77,461 (-10.01%)

$86,073 (149.38%)

$34,515 (29.09%)

HEPA Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-225.00% (-226.56%)

-68.90% (-122.98%)

-30.90% (65.67%)

-90.00% (8.91%)

Return on Average Assets (ROAA)

-151.60% (-158.70%)

-58.60% (-105.61%)

-28.50% (59.29%)

-70.00% (-2.19%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

2738.50% (279.21%)

-1528.10% (-41.83%)

-1077.40% (-49.35%)

-721.40% (-274.95%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.26 (48.33%)

-0.51 (79.02%)

-2.43 (-132.60%)

-1.04 (-18.93%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

1.93 (320.48%)

0.46 (-50.86%)

0.93 (91.39%)

0.49 (-58.82%)

Debt to Equity Ratio (D/E)

1.49 (613.94%)

0.21 (82.46%)

0.11 (-43.28%)

0.2 (-37.19%)

Earnings Per Share (EPS)

-12.32 (-4.41%)

-11.8 (-25.53%)

-9.4 (77.62%)

-42 (65.63%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-10.3 (-12.26%)

-9.18 (-2.86%)

-8.92 (73.44%)

-33.58 (54.95%)

Book Value Per Share (BVPS)

1.83 (-85.98%)

13.08 (-50.57%)

26.46 (-68.40%)

83.74 (-45.22%)

Tangible Assets Book Value Per Share (TABVPS)

4.56 (-71.17%)

15.81 (-45.37%)

28.93 (-70.07%)

96.66 (-47.31%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

1 (0%)

0 (0%)

0 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.1 (-87.42%)

0.8 (128.77%)

0.35 (203.54%)

-0.34 (46.10%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

3.31 (-53.85%)

7.16 (-39.67%)

11.88 (29.85%)

9.14 (2.29%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$40,903,182 (-16.95%)

-$34,975,241 (-11.55%)

-$31,354,886 (-92.94%)

-$16,250,991 (-113.36%)

Enterprise Value (EV)

-$4,988,447 (86.20%)

-$36,147,861 (-215.70%)

-$11,450,028 (-266.81%)

$6,864,102 (48.25%)

Earnings Before Tax (EBT)

-$49,335,064 (-9.43%)

-$45,083,898 (-37.78%)

-$32,722,168 (-61.01%)

-$20,323,354 (-155.77%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$49,258,468 (-9.47%)

-$44,996,273 (-37.91%)

-$32,627,236 (-61.06%)

-$20,257,610 (-175.08%)

Invested Capital

-$1,772,559 (-244.90%)

$1,223,256 (-49.93%)

$2,443,184 (14.28%)

$2,137,830 (-46.76%)

Working Capital

$12,197,744 (-74.91%)

$48,610,351 (-45.53%)

$89,245,372 (135.03%)

$37,972,472 (197.14%)

Tangible Asset Value

$18,094,397 (-69.97%)

$60,244,452 (-40.75%)

$101,681,555 (117.39%)

$46,774,329 (149.59%)

Market Capitalization

$14,054,090 (-38.61%)

$22,891,754 (-73.66%)

$86,896,790 (339.65%)

$19,765,085 (6.77%)

Average Equity

$21,741,281 (-66.94%)

$65,767,820 (-37.95%)

$105,983,478 (368.68%)

$22,613,240 (79.05%)

Average Assets

$32,273,966 (-58.27%)

$77,340,766 (-32.55%)

$114,666,092 (294.17%)

$29,090,674 (59.56%)

Invested Capital Average

-$1,801,223 (-161.06%)

$2,949,748 (-2.85%)

$3,036,254 (7.94%)

$2,812,962 (-26.77%)

Shares

4,337,682 (13.81%)

3,811,481 (0.01%)

3,811,263 (744.59%)

451,258 (161.31%)